> ## Content Index
> Fetch the complete content index at: https://www.huntingalphas.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pfizer's Q1 Update May Mark A Bottom In The Stock (Archive)
- URL: https://www.huntingalphas.com/pfizers-q1-update-may-mark-a-bottom-in-the-stock-archive-copy/
- Published: 2025-04-30T08:24:00.000Z
- Updated: 2026-02-28T17:01:22.000Z
- Description: Pfizer’s valuation and cost cuts hint at a forming bottom despite structural headwinds.
- Author: Vish (Hunting Alphas)
- Tags: 5-Minute Pitches, #noindex, Archive, #sa-origin, PFE, Healthcare

*This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.*

## Elevator Pitch

- Pfizer is facing some revenue pressures due to some higher Medicare discounts, and this has led to a small miss on revenue delivery in Q1 FY25.
- Pfizer is making meaningful improvements on profitability and is on track to realize a \~12.3% margin lift from 2024 until the end of 2027 from various cost saving initiatives.
- Stopping R&D of an obesity drug that had $10 billion annual revenue potential is a major setback and if PFE tries M&A instead, there is a risk of overpaying again.
- PFE stock is trading at trough valuations and at a larger-than-usual discount vs peers. So I think there is some decent margin of safety.
- Technical analysis vs SPX500 suggests PFE may be forming a bottom, but strong buyer signals are still absent.

Read the full article [here](https://seekingalpha.com/article/4779581-pfizer-q1-earnings-update-may-mark-bottom-in-stock?ref=huntingalphas.com).

#### Disclosures and Disclaimers

**Past performance ≠ future results. Not investment advice. See* [**full Disclaimer*](https://www.huntingalphas.com/disclaimer/)**.*